BIOMAT Database Logo BIOMAT Database Logo

Treatment of hyperlipoproteinemias with neomycin, probucol and tibric acid. 1977

T A Miettinen

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D010880 Piperidines A family of hexahydropyridines.
D011341 Probucol A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993). Biphenabid,DH-581,Lorelco,Lurselle,Panavir,Superlipid,DH 581,DH581
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid

Related Publications

T A Miettinen
[Treatment of hyperlipemia with tibric acid (TA)].
June 1978, Minerva medica,
T A Miettinen
[Treatment of hyperlipidemia with a new drug, tibric acid].
July 1976, Revista clinica espanola,
T A Miettinen
Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
January 1982, Artery,
T A Miettinen
[Clinical trial of tibric acid, a new hypolipidemic agent].
December 1974, Schweizerische medizinische Wochenschrift,
T A Miettinen
Hyperlipoproteinemias and dietary treatment.
December 1970, Postgraduate medicine,
T A Miettinen
[Hyperlipoproteinemias: classification and treatment].
January 1974, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
T A Miettinen
[Diagnosis and treatment of hyperlipoproteinemias].
February 1972, Schweizerische medizinische Wochenschrift,
T A Miettinen
Dietary treatment of hyperlipoproteinemias.
January 1973, Advances in experimental medicine and biology,
T A Miettinen
The treatment of hyperlipoproteinemias.
July 1979, Rational drug therapy,
T A Miettinen
[Drug treatment of hyperlipoproteinemias].
May 1977, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!